Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial | CANCERS |